Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson

BACKGROUND: Immune checkpoint inhibitors (ICPIs) are gaining increasing popularity as an efficacious treatment for advanced malignancies. ICPI treatment can be complicated by diarrhea and colitis. Systemic steroids are the first line treatment. Infliximab is reserved for severe refractory cases. We...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunother Cancer
Autori principali: Wang, Yinghong, Abu-Sbeih, Hamzah, Mao, Emily, Ali, Noman, Ali, Faisal Shaukat, Qiao, Wei, Lum, Phillip, Raju, Gottumukkala, Shuttlesworth, Gladis, Stroehlein, John, Diab, Adi
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946546/
https://ncbi.nlm.nih.gov/pubmed/29747688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0346-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi